Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3657_Библиотеки_им_академика_М_И_Перельмана.pdf
Скачиваний:
0
Добавлен:
30.08.2026
Размер:
49 Мб
Скачать
Outer sheath fired: core
41 Biopsy Techniques
Fig. 41.10 Schematic
depicting how tissue is obtained using core needle biopsy
457
Core biopsy needle
Needle inserted into mass
of tissue sampled
Needle removed with core of tissue
Table 41.2 FNA vs. core biopsy: which to choose [1012]
Advantages Disadvantages
FNA Lower complication
Core needle biopsy
Key Point
rate Smaller needle size Increased exibility Larger tissue sample Increased accuracy
Smaller tissue sample Requires presence of cytopathologist to determine sample adequacy Larger needle size Higher risk of complication
Single stick technique=biopsy device is inserted and
removed each time.
Coaxial technique = coaxial/trocar needle is left in
place and biopsy is performed through this needle each time.
When performing an ultrasound biopsy, the intervention­alist has the option of using a freehand technique or a needle guide. With the freehand technique, the interventionalist holds the ultrasound probe in one hand and the needle in the other to allow maximum exibility. This allows both the ultrasound and needle to be adjusted simultaneously in order to adjust the trajectory of the needle and visualize the entire shaft of the needle along its course. Depending on the anat­omy, the ultrasound probe can be placed directly adjacent to the needle or can be used in an off-axis way to utilize struc­tures as acoustic windows to follow the path of the needle as it traverses the tissues. This technique allows the physician to have maximal movement of the needle, and as such, the
physician must deal with all the degrees of freedom during movement of the needle.
Key Point
Freehand technique=no guide, maximum mobility. Needle guide technique = device to guide needle,
decreases needle mobility.
The needle guide technique utilizes a guide attached to the ultrasound probe such that the needle is aligned with the long axis of the ultrasound probe (Fig.41.11). The track of the needle path is usually displayed on the ultrasound moni­tor as a runway that the needle should follow (Fig.41.12). Utilizing this guidance system allows for the physician to negate many degrees of freedom and only have to account for advancing the needle a certain distance to reach the lesion. The downside of this technique is that the physician’s ability to make adjustments in the path of the needle is greatly reduced. The needle is locked into the positioning, and the physician cannot independently move the probe sep­arately from the needle to afford better visualization if needed during the biopsy. Additionally, with breathing or when traversing harder tissue planes, the needle can be deected away from the projected course.
A simple supercial biopsy may not require sedation and may only need to be performed with local anesthesia. For more involved biopsies or deeper structures, moderate or general anesthesia may be needed. Most pediatric biopsies are performed with general anesthesia. As for all anesthesia cases,
458
the patient must be NPO for 6h to decrease the risk of aspiration. In the outpatient setting, a patient must have a ride home if receiving anesthesia. Appropriate laboratory parameters must be checked prior to safely performing a procedure. This typi­cally includes PT, PTT, INR, and platelets within 30 days although exact timing is institutional dependent. Fibrinogen can also be checked for patients with liver dysfunction. Anticoagulant medications must be checked and held as appropriate to decrease the risk of bleeding. Arrangements for alternatives may need to be made in the interim.
S. Abay and A. B. Winick
The How To
1. ­ity, and patient status should be performed prior to initiation of the procedure
2. The patient should be appropriately positioned and scout imaging performed to ensure a safe route.
3. Anesthetize the tract under image guidance ensur­ing the pleural/peritoneal lining is adequately anesthetized.
4. Place needle into lesion using image guidance. For CT, this requires slowing advancing while checking using the CT to ensure the needle is in the proper trajectory.
5. Obtain biopsy using either single stick or coaxial technique. Typically three to four biopsies are per­formed to obtain adequate samples for pathology although this is institutional dependent.
6. For FNA biopsies the slides are created and analyzed
sampling. For core needle biopsies, the sample is
Fig. 41.11 Demonstration of a needle guide on the long axis of the
ultrasound probe. Note the limitation in operator movement of the needle
Most biopsies can be performed as an outpatient with a short recovery period following the procedure. More inva­sive procedures or those following anesthesia require a lon­ger recovery time to monitor for complications and allow recovery from sedation.
Fig. 41.12 (a) Focal liver biopsy with needle guide. A 52-year-old
male with history of carcinoid. Found to have new hepatic mass on MRI. The lesion is seen here on ultrasound as a hypoechoic mass
(arrow). (b) Biopsy needle (arrow) is seen within the liver mass. Pathological diagnosis was metastatic well-differentiated neuroendo­crine tumor
41 Biopsy Techniques
459
Organ Specics
Nearly any organ in the body with the exception of the brain can be biopsied percutaneously. Specic considerations are warranted for each organ as they carry different risks and benets (Table 41.3). Lung biopsies are frequently per­formed for determination of malignancy versus infection as both can have similar imaging appearance and have increased FDG uptake on PET-CT.Specic risks associated with lung or pleural biopsies include the risk of a pneumothorax or hemoptysis. There are several techniques that can be used to decrease the risk of post-biopsy pneumothorax including aspirating any obvious pneumothorax or administration of a sealant into the tract during nal retraction of the needle to seal the hole. If the patient develops an expanding pneumo­thorax or dyspnea related to the pneumothorax, a chest tube may be warranted for treatment (refer to Chap. 42 for more information), which requires inpatient admission.
A liver biopsy can be performed both percutaneously and
through the transjugular approach. Percutaneous can be
performed via the subcostal or intercostal approach depending on liver positioning (see Fig.41.12). If intercostal approach is chosen, all attempts should be made to avoid crossing the pleural space to avoid a pneumothorax. The transjugular approach is performed if the patient is at increased risk of bleeding which cannot be corrected with medications or infusions. Access is gained through the internal jugular vein via the Seldinger technique and a catheter, and wire is advanced into the hepatic veins, most commonly the middle hepatic vein. Free and wedged pressures can be obtained to determine the portal vein/hepatic vein pressure gradient. Appropriate position is selected to ensure that adequate liver parenchyma is present to avoid transgression of the liver cap­sule. A long biopsy needle is placed through the guide cath­eter and biopsy is performed (Fig. 41.13). Following the biopsy, contrast can be injected to ensure there is no extrava­sation through the liver capsule. Possible complication fol­lowing the transjugular approach includes renal injury if the biopsy device inadvertently traverses the hepatic capsule into the kidney.
Table 41.3 Organ-specic metrics for biopsies including success rate, complication rate, and indication for procedure
Organ Success rate Complications Indications Lung 85% [15, 16] Pneumothorax
Liver 76% [17] Bleeding, pneumothorax, bile injury
Renal 95% [9] Bleeding, injury to urinary system
MSK 74–96% [9] Bleeding, fracture
Thyroid 84% [13] Bleeding
Lymph node
Pancreas 93–98% [10, 20] Bleeding
a
No data available
a
Coaxial 9–19% FNA 27% Hemoptysis Coaxial 4–10% FNA 2–5%
0–6% [9]
<2% [9]
<2% [9]
1–9% [14]
Bleeding <1% [19]
1–8% [9]
Primary malignancy Metastatic disease Benign disease Infection Inammatory
Non-focal Cirrhosis Steatohepatitis Hemochromatosis Wilson’s disease Focal Primary malignancy Metastatic disease Benign disease Non-focal AKI Chronic kidney disease Focal Primary malignancy Benign disease Primary malignancy Benign mass Infection (for culture, not diagnosis) Primary malignancy [18] Benign disease [18] Recurrence s/p thyroidectomy [18] Parathyroid mass
Primary malignancy Reactive (infection/inammation) Primary malignancy
460
Fig. 41.13 Transjugular liver
biopsy. Fluoroscopic image shows an example of a transjugu­lar liver biopsy. The long biopsy needle (arrow) is within the liver parenchyma, having been advanced via the right internal jugular vein
S. Abay and A. B. Winick
Fig. 41.14 (a) A 55-year-old female status post-liver transplantation
for HCC with increasing size of splenic lesion (red arrow). The FNA biopsy needle can be seen just entering the splenic parenchyma. (b) Core needle biopsy shows the needle traversing through the splenic lesion. (c) Post-biopsy the patient endorses signicant abdominal pain and became hypotensive. CTA demonstrates evidence of active extravasation (red
arrow) within the spleen with a large perisplenic hematoma. This tracked down the left paracolic gutter and into the pelvis as well. Selective (d) and supra-selective (e) splenic angiogram did not demonstrate any evi­dence of active extravasation. The mid- segmental splenic artery branch was embolized empirically with Gelfoam. Final pathology was consis­tent with a hemangioma
41 Biopsy Techniques
Key Point
Remember, posteriorly the pleura ends at the 12th rib and the lung at the 10th rib.
Key Point
Liver biopsy can be performed percutaneously or via a transjugular approach. Risk of transjugular approach includes renal injury.
One of the most common complications following any biopsy is the risk of bleeding. Frequently bleeding is self­limited and requires no intervention. Occasionally, bleeding can become life-threatening and require trans-arterial inter­vention for treatment (Fig.41.14).
Breast biopsies can be performed by ultrasound, mammog­raphy, or MRI guidance, typically by dedicated breast radiolo­gists. This is used to differentiate benign from malignant lesions. Prostate biopsies, typically performed by urologists, can be targeted or nontargeted when a PSA is elevated or there is a high clinical index of suspicion for malignancy.
With advances in imaging quality, availability, and tools, image-guided biopsies have usurped surgical biopsies as a minimally invasive option for obtaining tissue sampling. It is not only less invasive, it is associated with fewer compli­cations, a higher success rate, and is cost-effective.

References

1. Kaadan AN. Albucasis and thyroid surgery. Paper presented at:
39th international congress on the history of medicine, 2004; Bari, Metaponto Italy.
2. Diamantis A, Magiorkinis E, Koutselini H. Fine-needle aspira-
tion (FNA) biopsy: historical aspects. Folia Histochem Cytobiol. 2009;47(2):191–7.
3. Webb AJ. Early microscopy: history of ne needle aspira-
tion (FNA) with particular reference to goiters. Cytopathology. 2001;12:1–6.
4. Rosa M. Fine-needle aspiration biopsy: a historical overview.
Diagn Cytopathol. 2008;36(11):773–5.
461
5. Farrell RJ, Smiddy PF, Pilkington RM, Tobin AA, Mooney EE, Temperley IJ, et al. Guided versus blind liver biopsy for chronic hepatitis C: clinical benets and costs. JHepatol. 1999;30(4):580–7.
6. Maya ID, Maddela P, Barker J, Allon M.Percutaneous renal biopsy: comparison of blind and real-time ultrasound-guided technique. Semin Dial. 2007;20(4):355–8.
7. Cesur M, Corapcioglu D, Bulut S, Gursoy A, Ender Yilmaz A, Erdogan N, Kamel N. Thyroid. 2006;16(6):555–61. https://doi.
org/10.1089/thy.2006.16.555.
8. Watkinson A, Adam A. Interventional radiology: a practical guide, vol. 42. NewYork: Radcliffe Medical Press; 1996. (ISBN 1 85775031 4)
9. Gervais DA, Sabharwal T, editors. Interventional radiology pro­cedures in biopsy and drainage. London: Springer-Verlag London Limited; 2001. (ISBN 978-1-84800-899-1)
10. Tyng CJ, Almeida MFA, Barbosa PN, Bitencourt AG, Berg JA, Maciel MS, etal. Computed tomography-guided percutaneous core needle biopsy in pancreatic tumor diagnosis. World JGastroenterol. 2015;21(12):3579–86.
11. Rotten D, Levaillant JM, Leridon H, Letessier A, Sandres M.Ultrasonographically guided ne needle aspiration cytology and core-needle biopsy in the diagnosis of breast tumors. Eur JObstet Gynecol Reprod Biol. 1993;49:175–86.
12. Willems SM, van Deurzen CH, van Diest PJ. Diagnosis of breast lesions: ne-needle aspiration cytology or core needle biopsy? A review. JClin Pathol. 2012;65:287–92.
13. Choi SH, Han KH, Yoon JH, Moon HJ, Son EJ, Youk JH, etal. Factors affecting inadequate sampling of ultrasound-guided ne­needle aspiration biopsy of thyroid nodules. Clin Endocrinol. 2011;74(6):776–82.
14. Polyzos SA, Anastasilakis AD. Clinical complications following thyroid ne-needle biopsy: a systematic review. Clin Endocrinol. 2009;71:157–65.
15. Khankan AA, Al-Muaikeel M.Image-guided percutaneous trans­thoracic biopsy in lung cancer--emphasis on CT-guided technique. JInfect Public Health. 2012;5(Suppl 1):S22–30.
16. Otto S, Mensel B, Friedrich N, Schäfer S, Mahlke C, von Bernstorff W, et al. Predictors of technical success and rate of complications of image-guided percutaneous transthoracic lung needle biopsy of pulmonary tumors. PLoS One. 2015;10(4):e0124947.
17. Fryer E, Wang LM, Verrill C, Fleming K. How often do our liver core biopsies reach current denitions of adequacy? JClin Pathol. 2013–201440;66:1087–9.
18. Haugen BR, Alexander EK, et al. American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;26(1):1–133. 2016.
https://doi.org/10.1089/thy.2015.0020.
19. Mueller M, Wittich G, Oeztuerk S, Kratzer W, Haenle M, Mason R.Sonographically guided lymph node biopsy: complication rates. Open JClin Diagn. 2012;2:30–5.
20. Zamboni GA, D'Onofrio M, Idili A, Malagò R, Iozzia R, Manfrin E, Mucelli RP. Ultrasound-guided percutaneous ne-needle aspi­ration of 545 focal pancreatic lesions. AJR Am J Roentgenol. 2009;193(6):1691–5.
Ascites andPleural Effusion
KatherineSterner andArunKrishnaraj

Introduction

Ascites and pleural effusions are abnormal uid collections within the peritoneal cavity and thoracic cavity, respectively. Etiologies include underlying abnormalities in hydrostatic and/or oncotic pressures, vascular permeability, or lymphat­ics. Treatment is aimed at the underlying cause. Initial diag­nosis depends on clinical correlation with imaging ndings and, oftentimes, uid sampling with percutaneous needle drainage procedures including paracentesis and thoracente­sis. Percutaneous image-guided procedures have become the standard of care due to their cost-effectiveness and low patient morbidity.

Pathophysiology

Ascites
42
blood volume activates the sympathetic nervous system and renin- angiotensin- aldosterone system, which results in increased sodium and water retention. In combination with decreased plasma oncotic pressure due to hypoalbu­minemia and increased portal pressures, excess uid accu­mulates in the peritoneal cavity [3, 4].
Key Point
The most common cause of ascites is cirrhosis.
Additional causes of ascites include obstructive, infec­tious, inammatory, traumatic, and malignant etiologies as well as volume overload states as described in Table 42.1. Accurate diagnosis is based on calculation of serum ascites albumin gradient (SAAG) from a sample of ascites [5, 6].
Ascites is dened as an abnormal accumulation of uid within the peritoneal cavity. Portal hypertension due to cir­rhosis is the most common cause of ascites in the United States, accounting for 85% of cases [1, 2]. The pathophysi­ology underlying cirrhotic ascites is multifactorial and not completely understood. Currently, the most accepted the­ory proposes that hepatic sinusoidal hypertension results in increased production of nitric oxide causing splanchnic and peripheral vasodilation. Decreased effective arterial
Key Point
SAAG=serum albumin– ascites albumin. SAAG <1.1 suggests a peritoneal cause of ascites. SAAG >1.1 suggests a non-peritoneal cause of ascites
including portal hypertension.
Pleural Eusion
K. Sterner University of Virginia Health System, Department of Radiology and Medical Imaging, Charlottesville, VA, USA e-mail: kls7qx@virginia.edu
A. Krishnaraj ( Division of Body Imaging, UVA School of Medicine, University of Virginia Health System, Department of Radiology and Medical Imaging, Charlottesville, VA, USA e-mail: arunk@virginia.edu
© Springer International Publishing AG, part of Springer Nature 2018 N. A. Keefe et al. (eds.), IR Playbook, https://doi.org/10.1007/978-3-319-71300-7_42
*)
A pleural effusion is an abnormal accumulation of uid within the pleural space. Approximately 2–5mL of physio­logic pleural uid is normally present to function as a lubri­cant during respiration [1]. Excess pleural uid accumulates in this space when there is an imbalance between uid pro­duction and clearance. Etiologies that induce uid imbalance include increased hydrostatic forces, decreased oncotic pres­sure, increased capillary permeability, or obstructed or
463
464
Table 42.1 Etiologies of ascites [5]
Disease Pathophysiology Budd-Chiari syndrome Hepatic venous outow tract obstruction:
Heart failure/renal failure Malignant ascites/ peritoneal carcinomatosis
Nephrotic syndrome, protein losing enteropathy, severe malnutrition Chylous ascites Disruption of lymphatics due to trauma or
Pancreatic ascites Massive accumulation of pancreatic uid
Hemoperitoneum Traumatic due to accident, surgery, or
Tuberculous peritonitis Tuberculous implants on visceral and
Table 42.2 Etiologies of pleural effusion
Transudate Exudate Congestive heart failure Cirrhosis Renal failure Nephrotic syndrome Connective tissue disease Hypoalbuminemia Pancreatitis Pulmonary embolism Chylothorax
a
Most common etiologies
a
a
Thrombosis, phlebitis, or external compression of suprahepatic IVC Volume overload state causing increased venous pressures and transudation of uid Commonly seen in ovarian, breast, colon, pancreas, and hepatocellular carcinomas. The tumor cells seed the peritoneum and produce excess uid in the peritoneal cavity and/or obstruct lymphatics Ascites results from hypoalbuminemia, which decreases plasma oncotic pressure resulting in third spacing of uid
obstruction as seen in malignancy
in the peritoneal cavity either due to chronic pancreatitis, pancreatic pseudocyst rupture, or traumatic injury
biopsy. Occasionally due to peritoneal carcinomatosis causing bleeding
parietal peritoneum secrete proteinaceous uid, similar mechanism to peritoneal carcinomatosis
a
Parapneumonic effusion/exudate Malignancy Tuberculosis
Drug-induced Esophageal rupture Hemothorax Empyema
a
a
K. Sterner and A. Krishnaraj
Key Point
New pleural effusions without denite cause or those
that fail conventional therapy require diagnostic
thoracentesis.
Congestive heart failure is the most common cause of a transudative pleural effusion. Transudative effusions are typically bilateral and often symmetric in size. Parapneumonic effusions are the most common cause of exudative effusions and occur as a complication of pneumo­nia. Three stages are described [11]:
• Stage 1: Exudative stage
– Simple parapneumonic effusion: Pulmonary inam-
mation resulting in increased vascular permeability of visceral pleural. Effusions in this stage are small and sterile.
• Stage 2: Fibropurulent stage
– Empyema: Pleural uid has become infected with
frank pus in the pleural space. The effusion is loculated with thickened pleura.
• Stage 3: Organization stage
– Pleural peel or brothorax: Results from chronic
empyema and extensive pleural brosis. This causes lung restriction and decreased lung volume, also known as “trapped lung.”
Malignant pleural effusion, the second most common cause of an exudative effusion, results from obstruction of lymphatics by tumor cells and/or increased vascular perme­ability [10]. Malignant effusions are typically large and uni­lateral or bilateral and asymmetric as opposed to more symmetric pleural effusions caused by congestive heart fail­ure. Cancers that can metastasize to the pleura and cause increased pleural uid production include lung, breast, geni­tourinary, and gastrointestinal cancers and lymphoma [10].
damaged lymphatics (Table42.2) [7]. Pleural effusions are classied as either a transudate, where there is an imbalance in hydrostatic forces or an exudate, characterized by increased protein characteristic of underlying pleural disease [7, 8]. This distinction is based on Light’s criteria where pleural uid is classied as an exudate if one of the following criteria is met [810]:
Pleural uid protein/serum protein >0.5 Pleural uid LDH/serum LDH >0.6 Pleural uid LDH >2/3 the upper limit of normal serum
LDH

Clinical Indication

Ascites
Indications to start treatment for ascites are based on patient symptomatology including abdominal pain due to abdominal distension, shortness of breath as a result from increased abdominal girth and mass effect on the diaphragm, weight gain, or anorexia [12]. Physical exam can reveal a distended abdomen, bulging anks, a uid wave, or shifting dullness [12]. Specic signs relating to etiology may also be present:
42 Ascites andPleural Eusion
465
• Liver disease: Palmar erythema, spider angiomata, and caput medusa
• Malignancy
– Virchow node – left supraclavicular adenopathy as
seen in upper abdominal malignancy
– Sister Mary Joseph nodule – rm umbilical nodule;
suggests peritoneal carcinomatosis
• Heart failure: Increased jugular venous pressure, ana­sarca, or lower extremity edema which can also be seen in renal disease
Ascites is graded on a 1+ to 4+ scale.
• 1+: Only detectable on careful physical examination
• 2+: Easily detectable, however small volume
• 3+: Large volume ascites, without a tense abdomen
• 4+: Large volume ascites with a tense abdomen
Imaging is obtained to assess the volume and character­istics of the uid present [13]. Ultrasound is the most cost­effective means of assessing ascites, detecting as little as 10cc [12, 14]. Fluid typically collects in the most depen­dent regions in a supine patient: the hepatorenal recess (Morrison’s pouch) in the abdomen or the rectouterine pouch (pouch of Douglas) in the pelvis (Fig.42.1). Simple uid is anechoic sonographically. Floating debris or septa­tions can be seen in more complex or loculated collections, respectively. On conventional radiography, ascites mani­fests as diffusely increased density or ground-glass opacity of the abdomen with indistinct margins of the solid organs. The anks may appear bulging and bowel loops will be centralized (Fig.42.2). For these ndings to be conspicu­ous, at least 500mL of uid must be present [12, 15]. CT is the most sensitive exam for detecting small amounts of intraperitoneal uid and can also be useful in uncovering
Fig. 42.1 Ultrasound of the abdomen. (a) Transverse view through the
left hepatic lobe. Anechoic uid (ascites) surrounds the liver. (b) Long­axis view of the right kidney. Ascites is seen dependently within
Morrison’s pouch (arrow). (c) Ultrasound of the pelvis. Ascites is also seen in the pelvis surrounding loops of bowel (arrows)
466
an underlying etiology (Fig. 42.3) [12, 13]. A nodular, shrunken liver with sequela of portal hypertension such as varices and splenomegaly are typical imaging ndings in cirrhosis. Peritoneal nodules, omental caking, tumor, and lymphadenopathy may be seen in malignancy. The uid density can also be helpful in determining an etiology: Hounseld units (HU) <20 suggest transudate, >20 exu­date, and 45–65 hemoperitoneum.
Fig. 42.2 Conventional radiograph of the abdomen demonstrates dif-
fuse ground-glass opacity and centralization of bowel loops (arrows) indicating ascites
K. Sterner and A. Krishnaraj
Key Point
CT is the most sensitive exam, while US is the most cost-effective exam for detecting ascites. First-line evaluation for ascites is by US.
Pleural Eusion
Symptoms of pleural effusions are nonspecic and include cough, dyspnea, pleuritic chest pain, fever, night sweats, and/or weight loss if secondary to malignancy. Physical exam ndings include decreased breath sounds on ausculta­tion, dullness to percussion, and decreased tactile fremitus if a large volume is present, typically at least 300mL [16]. Chest radiographs are typically the initial diagnostic imaging exam performed when a pleural effusion is suspected. On a PA chest radiograph, 175mL of pleural uid must be present to blunt the lateral costophrenic angles; 75mL is necessary to blunt the posterior costophrenic angle, while a decubitus view can detect as little as 10mL of pleural uid (Fig.42.4) [7, 9, 11]. CT can detect very small volumes of uid and, as with ascites, can aid in identifying the underlying lung pathology [7, 10]. Simple effusions will appear as hypoat­tenuating dependent collections, measuring between 0 and 10 Hounseld units (HU) (Fig. 10.5 a, b); hemothorax will have HU between 45 and 65 (Fig.42.5c). Loculated collec­tions are nondependent and have a lenticular shape (Fig.42.6). A parapneumonic effusion is a reactive simple effusion with concomitant pneumonia (Fig.42.7). An empy­ema will demonstrate thickened and enhancing pleural,
Fig. 42.3 Contrast-enhanced axial CT through the upper abdomen. (a)
Ascites in the lower abdomen= surrounding loops of bowel (arrow). The region of interest (ROI, as demarcated by the circle) demonstrates Hounseld units of 9 consistent with simple uid. (b) Axial image
through the upper abdomen of a different patient demonstrating ascites (solid arrow) and a shrunken, nodular liver (dotted arrow) consistent with cirrhosis
42 Ascites andPleural Eusion
467
Fig. 42.4 Conventional radiographs of the chest. (a) PA chest radio-
graph demonstrates an opacity forming a meniscus in the right costo­phrenic angle, representing a small pleural effusion. (b) Same patient,
Fig. 42.5 Non-enhanced CT of the chest demonstrates a simple pleu-
ral effusion, left greater than right (solid arrows). The dotted arrow points to partially collapsed lung
lateral view of the chest demonstrates a small right pleural effusion (arrows). (c) PA chest radiograph of a different patient demonstrates a large pleural effusion (arrow)
known as the split pleura sign (Fig.42.8) [10]. Ultrasound is an additional imaging method to assess pleural effusion and can detect as little as 20mL of pleural uid [17] (Fig.42.9a). Ultrasound can further characterize effusions as complicated by demonstrating debris, loculation, or septation (see Fig.42.9b) [7, 9, 10].
Key Point
Decubitus radiograph is the most sensitive technique
for diagnosing a pleural effusion, detecting as little as
10cc.
Key Point
Empyemas must be drained either surgically or percu-
taneously in addition to appropriate antibiotic therapy.